or Try an Advanced Search...

    Genentech Stocks List

    Symbol Grade Name % Change
    KA F Kineta, Inc. 1.81
    SGMO F Sangamo BioSciences, Inc. -4.01
    ADPT F Adaptive Biotechnologies Corporation 5.02
    OTLK D Outlook Therapeutics, Inc. 0.00
    LXRX D Lexicon Pharmaceuticals, Inc. 3.03
    BIIB D Biogen Idec Inc. -1.21
    XENE C Xenon Pharmaceuticals Inc. 1.20
    SNDX C Syndax Pharmaceuticals, Inc. -0.50
    ASND C Ascendis Pharma A/S 0.06
    EXEL B Exelixis, Inc. 0.89
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biotechnology Cancer Medicine Monoclonal Antibodies Biopharmaceutical Diabetes Drug Discovery Life Sciences Solid Tumors Acne Antibodies Breast Cancer Cancer Cell Cardiovascular Disease Disease Hypertension Immunology Infectious Diseases Lung Cancer Lymphoma

    Related ETFs - A few ETFs which own one or more of the above listed Genentech stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 16.22
    PBE C PowerShares Dynamic Biotech & Genome 10.25
    BBP C BioShares Biotechnology Products Fund 8.69
    IBRN C iShares Neuroscience and Healthcare ETF 8.34
    BIS C ProShares UltraShort Nasdaq Biotechnology 8.04
    View all Genentech ETFs...
    Compare ETFs
    Compare BBP to BIS Compare PBE to BIS Compare PBE to IBRN

        Genentech Stocks Recent News

        Date Stock Title
        May 2 LXRX Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
        May 2 LXRX Lexicon Pharmaceuticals Reports Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic ...
        May 2 ASND Ascendis Pharma reports Q1 results
        May 2 LXRX Lexicon Pharmaceuticals GAAP EPS of -$0.20 in-line, revenue of $1.13M misses by $0.27M
        May 2 SGMO Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
        May 2 LXRX Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
        May 2 ASND Ascendis Pharma Reports First Quarter 2024 Financial Results
        May 2 XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
        May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
        May 2 OTLK Outlook Therapeutics® to Present at the Retina World Congress 2024
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 1 LXRX Lexicon Pharmaceuticals Q1 2024 Earnings Preview
        May 1 ASND Ascendis Pharma Q1 2024 Earnings Preview
        May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        May 1 EXEL Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
        May 1 EXEL Q1 2024 Exelixis Inc Earnings Call
        May 1 SNDX Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
        May 1 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biotechnology Cancer Medicine Monoclonal Antibodies Biopharmaceutical Diabetes Drug Discovery Life Sciences Solid Tumors Acne Antibodies Breast Cancer Cancer Cell Cardiovascular Disease Disease Hypertension Immunology Infectious Diseases Lung Cancer Lymphoma
        Genentech

        Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of September 2017, Genentech employed 15,064 people.

        More about Genentech
        Browse All Tags